Adamas Trust, Inc. is a real estate investment trust, which engages in the acquisition, investment, finance, and management of mortgage-related single-family and multi-family residential assets. The company is headquartered in New York City, New York and currently employs 221 full-time employees. The company went IPO on 2004-06-24. Its objective is to deliver long-term stable distributions to its stockholders. Its investment portfolio includes credit sensitive single-family and multifamily assets, and more traditional types of fixed-income investments that provide coupon income, such as Agency residential mortgage-backed securities (RMBS). Its targeted investments include residential loans, including business purpose loans; agency RMBS; non-agency RMBS; structured multifamily property investments such as preferred equity in, and mezzanine loans to, owners of multifamily properties; other mortgages, such as residential housing- and credit-related assets and strategic investments in companies from which it purchases, or may in the future purchase, its targeted assets.
Adamas Trust Inc の最大収益セグメントは Research and Development of Plant Gene Editing で、最新の利益発表における収益は 4,262,000 です。地域別に見ると、United States が Adamas Trust Inc の主要市場であり、収益は 4,262,000 です。